NIZHPHARM

History

2025

Transfer to the management of the Russian company Pharmirus

On April 4, 2025, the president Russia Vladimir Putin signed a decree according to which the Stada Nizhny Novgorod Chemical and Pharmaceutical Plant (Nizhfarm JSC) owned by the Russian company "." Pharmirus The latter carries out comprehensive supplies of medicines and equipment according to project applications.

Nizhpharm left the German group Stada in 2023. Thereafter, the company operated under Luxembourg-based Nidda Lynx S.A.R.L., which is part of Nidda Healthcare Holding Gmb. At the same time, Nidda Lynx S.A.R.L. is also the owner of Stada.

𝓲

Фото: Kremlin website

Add to the list of movable and immovable property, securities, shares in the authorized (folding) capital of Russian legal entities and property rights in respect of which temporary management is introduced<...>, 100% of the shares of Nizhny Novgorod Chemical and Pharmaceutical Plant JSC owned by Nidda Lynx S.A.R.L., "Pharmirus, - said in the decree of the President of the Russian Federation.

The Pharmirus website says that the company works on individual applications: it selects the necessary products for the customer according to the required characteristics (properties, cost, brands). At the same time, not only pharmaceutical products are supplied, but also medical devices and complex equipment. After delivery, Pharmirus employees install equipment on site, as well as train personnel to work on it. If necessary, maintenance of the delivered equipment is carried out.

The founder and CEO of Pharmirus is Anna Zalogina, a former employee of R-Pharm. According to the SPARK-Interfax service, the company took part in 13 tenders. There are no enforcement proceedings against Pharmirus. The organization participated in one arbitration case as a plaintiff.^[1]

Appointment of Dmitry Isachenko as CEO

On April 8, 2025, the Nizhny Novgorod Chemical and Pharmaceutical Plant (Nizhfarm) changed its general director. Now the post is occupied by Dmitry Isachenko. The new general director replaced Oksana Pozdnyakova in this position. In early 2025, Dmitry Isachenko was appointed chairman of the liquidation commission of the Fund for Assistance to the Development of State Bodies for Civil Defense, Emergencies and Disaster Management. From April to August 2024, he served as chairman of the Krylatskie Hills Autonomous Non-Profit Organization. Read more here

2023: Appointment of Oksana Pozdnyakova as general director of the Nizhfarm plant

In mid-November 2023, the general director of the pharmaceutical company Nizhfarm changed: he was appointed Oksana Pozdnyakova, who previously headed the business division of over-the-counter drugs Consumer Healthcare of Stada in Russia. She headed the Nizhny Novgorod enterprise instead of Lyudmila Matveeva, who stayed at this post for a little over a year. Read more here.

2022: Appointment of Larisa Matveyeva as General Director of the Nizhfarm plant

In August 2022, it became known about the appointment of Larisa Matveeva to the post of General Director of Nizhfarm JSC (part of the Stada group of companies). In this post, she replaced Stefan Eder, who a few months earlier was appointed head of the global company Stada in all European markets. Read more here.

2010: Tasks "Nizhpharm"

The Russian holding STADA CIS is engaged in the development, production and sale of drugs in the territory countries CIS and the Baltic States, is part of the international STADA Group.

As of August 2010, the parent company of the holding was NIZHFARM, whose tasks included planning, consolidation of reporting, as well as analyzing the activities of the Holding's companies: NIZHFARM (g.) Nizhny Novgorod , MAKIZ-PHARMA (g.), Moscow SKOPINFARM (Ryazan region) - production of products;, STADA Marketing STADA Ukraine, STADA Central Asia, STADA Azerbaijan, STADA Armenia - marketing sale distribution of products; STADA PharmDevelopment - - R&D subdivision.